• Protein A/G Magnetic Beads: Practical IP Workflow

  2026-08-25

  Protein A/G Magnetic Beads (SKU K1305) provide Fc-directed magnetic capture for antibody purification, immunoprecipitation, co-immunoprecipitation, and Ch-IP from complex samples. They are appropriate for research workflows requiring controlled antibody immobilization and magnetic separation, but binding capacity, antibody compatibility, and assay performance should be established experimentally rather than inferred from the product description.

• Aurora Kinase A in High-Risk Retinoblastoma

  2026-08-25

  A 2024 American Journal of Pathology study identifies AURKA overexpression as a feature of human retinoblastoma associated with histopathologic high-risk factors and poor chemotherapy response. By combining patient-tissue analysis with genetic and pharmacologic studies in cellular, patient-derived, xenograft, and enucleated-tumor models, the work supports AURKA as a mechanistically relevant target for retinoblastoma research.

• Bsa I (RNase-free): Practical DNA Cleavage Guide

  2026-08-24

  Bsa I (RNase-free) provides sequence-directed, type IIS DNA cleavage for gene cloning, DNA manipulation, and other molecular biology research workflows where RNA contamination must be minimized. It is intended for research use with the supplied 10X Cut rA Buffer and should not be used for diagnostic, clinical, or medical applications.

• Live-Dead Cell Staining Kit I: Cytocompatibility

  2026-08-24

  Use the Live-Dead Cell Staining Kit I to distinguish metabolically active mammalian cells from membrane-compromised cells in rapid cytocompatibility and cytotoxicity workflows. Its two-probe format is especially useful for translating nanoparticle disinfection research into host-cell safety assays without incorrectly applying a mammalian stain to bacteria.

• CBD and Orofacial Inflammatory Pain Mechanisms

  2026-08-23

  A 2026 Brain Research Bulletin study shows that cannabidiol (CBD) reduces both inflammatory orofacial nociception and pain-related affective deficits through distinct peripheral and central endocannabinoid mechanisms. Its integrated behavioral, biochemical, imaging, and fiber-photometry design provides a useful framework for evaluating cannabinoid signaling in multidimensional pain models.

• Recombinant Human EGF for Reliable Cell Assays

  2026-08-22

  A scenario-based guide to using Epidermal Growth Factor (EGF), human recombinant in proliferation, viability, and cytotoxicity workflows. It explains how SKU P1008 supports controlled EGFR stimulation through defined quality, activity, reconstitution, and storage specifications.

• Primary Antibody Dilution Buffer for CNS Lymphoma

  2026-08-22

  Primary Antibody Dilution Buffer supports more consistent antibody preparation for IHC, ICC, and antibody-based ISH in difficult CNS lymphoma specimens. Its BSA- and Triton X-100-containing formulation helps balance tissue penetration, antibody stability, and background control while researchers investigate SLC2A5-associated metabolic adaptations.

• RAB31 and the ESCRT-Independent Exosome Pathway

  2026-08-21

  The reference study identifies active RAB31 as a coordinator of an ESCRT-independent exosome pathway. It links EGFR phosphorylation, flotillin-dependent intraluminal vesicle formation, and RAB7 inhibition to show how one regulatory module both generates exosome precursors and protects them from lysosomal degradation.

• Prunin Targets SVA IRES-Mediated Translation

  2026-08-20

  The reference study identifies prunin as an inhibitor of Senecavirus A replication and links its activity to suppression of IRES-mediated translation. By combining time-of-addition assays, an IRES-dependent reporter, RNA pull-down experiments, and mouse infection studies, the authors connect a cellular antiviral phenotype with disruption of hnRNP A2B1, hnRNP K, and SAM68 interactions.

• Canagliflozin Remodels Mitochondria in Diabetic Kidneys

  2026-08-20

  A 2025 study shows that canagliflozin improves proximal tubular mitochondrial architecture and bioenergetics in hypertensive–diabetic male mice, while females exhibit a milder structural response without measurable bioenergetic improvement. The findings connect SGLT2 inhibition with mitochondrial remodeling and provide a mechanistic framework for studying kidney protection beyond glycemic control.

• AICAR for AMPK–Mitophagy Research

  2026-08-19

  AICAR provides a focused way to interrogate AMPK-linked energy metabolism regulation and mitochondrial quality control. This article translates sarcopenic-obesity findings into rigorous assay design, controls, and interpretation strategies.

• Primidone Research: TRPM3, RIPK1 & ALS Workflows

  2026-08-19

  Primidone (Mysoline) supports a practical bridge from TRPM3 channel inhibition to RIPK1-centered neurodegeneration studies, with a separate biochemical workflow for hPON1 inhibition. This guide emphasizes concentration selection, assay controls, animal-model dosing, and troubleshooting for reproducible translational research.

• Paclitaxel Workflows for Senescence-Targeted Cancer Research

  2026-08-18

  Paclitaxel (Taxol) provides a controllable microtubule-stress workflow for separating acute mitotic arrest from persistent chemotherapy-induced senescence. This guide translates a landmark breast cancer study into practical dosing, recovery, senolytic, imaging, and troubleshooting strategies for reproducible cancer research.

• Targeted Amikacin Delivery into Mycobacterial Granulomas

  2026-08-18

  The reference study developed a dendritic-cell delivery strategy that transported fluorescently labeled amikacin into granulomas in mice infected with Mycobacterium avium. Its findings support organism-directed antibiotic delivery as a preclinical approach for increasing local drug exposure while limiting detectable systemic exposure, although long-term efficacy and clinical translation remain unresolved.

• KR-12–Cu(II) Binding: Theory Meets Experiment

  2026-08-17

  The 2024 Dalton Transactions study combines potentiometric titration, isothermal titration calorimetry, and GFN2-xTB/ALPB calculations to clarify how the LL-37-derived peptide KR-12 interacts with Cu(II). Its key contribution is a residue- and atom-level interpretation of a dynamic metal–peptide system, showing that backbone oxygen atoms dominate coordination while Asp26 and Arg29 help define favorable binding modes.

8557 records 1/571 page Next 12345 下5页 Last page